Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,891
Closed -$172K 400
2023
Q3
$172K Buy
1,891
+548
+41% +$56.5K 0.07% 87
2023
Q2
$151K Buy
+1,343
New +$142K 0.02% 184
2022
Q1
Sell
-17
Closed -$2K 672
2021
Q4
$2K Buy
+17
New +$2.11K ﹤0.01% 660

Other funds holding XYL

Arlington Partners's XYL Position: Q4 2023 in Review

Arlington Partners sold out of Xylem (XYL) in Q4 2023, closing a stake of 1,891 shares — an estimated $172K sold.

Arlington Partners first reported a position in XYL in Q4 2021 and held it in 3 quarters. The position peaked at $172K in Q3 2023. 922 funds tracked by Wall St. Rank hold XYL as of Q4 2023.

  • Arlington Partners reported no remaining Xylem position as of Q4 2023 after selling out during the quarter.
  • Arlington Partners sold 1,891 Xylem shares in Q4 2023, an estimated $172K.
  • Arlington Partners first reported a position in Xylem in Q4 2021 and held it in 3 quarters.
  • Arlington Partners's Xylem position peaked at $172K in Q3 2023.
  • 922 funds tracked by Wall St. Rank held Xylem as of Q4 2023.

Based on Arlington Partners's 13F filing for Q4 2023, filed 24 Jan 2024.